I'm a long-term holder here and it was good to listen to some good news as delivered in this interview of 29 March 2017 with Mark Brewer Research Director Life Sciences at Finncap. Definitely worth a listen. In his view this stock is much undervalued compared to peers and he proffered some eyewatering forecasts. I'm not holding my breath for the highest of his predictions but he makes some excellent points.… Read More
good write up today on page 33 of shares mag - concludes with: In our view a commercially-focused chief executive and the results of the recent LiDCOrapid studies should prove an effective sales boost. (MD)
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.